Kate D. Sutherland

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer.

SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer.

Journal: bioRxiv : the preprint server for biology

Published: October 01, 2025

SMARCA4 Loss Promotes Late-Stage Tumor Progression in Nonneuroendocrine Small Cell Lung Cancer.

SMARCA4 Loss Promotes Late-Stage Tumor Progression in Nonneuroendocrine Small Cell Lung Cancer.

Journal: Molecular cancer research : MCR

Published: June 03, 2025

SMARCA4 loss promotes late-stage tumor progression in non-neuroendocrine small-cell lung cancer.

SMARCA4 loss promotes late-stage tumor progression in non-neuroendocrine small-cell lung cancer.

Journal: Molecular cancer research : MCR

Published: June 03, 2025

Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers.

Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers.

Journal: EMBO reports

Published: February 14, 2025

Breathing new insights into the role of mutant p53 in lung cancer.

Breathing new insights into the role of mutant p53 in lung cancer.

Journal: Oncogene

Published: July 08, 2024

A glycoprotein VI signaling defect in newly formed platelets generated in stress thrombopoiesis.

A glycoprotein VI signaling defect in newly formed platelets generated in stress thrombopoiesis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 25, 2024

A Multiplexed Approach to Assess Small Cell Lung Cancer Subtype Heterogeneity in Primary and Patient-Derived Tumor Samples.

A Multiplexed Approach to Assess Small Cell Lung Cancer Subtype Heterogeneity in Primary and Patient-Derived Tumor Samples.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 27, 2024

Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.

Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 04, 2023

On Target: An Intrapulmonary Transplantation Method for Modelling Lung Tumor Development in its Native Microenvironment.

On Target: An Intrapulmonary Transplantation Method for Modelling Lung Tumor Development in its Native Microenvironment.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: June 24, 2023

Next batter up! Targeting cancers with KRAS-G12D mutations.

Next batter up! Targeting cancers with KRAS-G12D mutations.

Journal: Trends in cancer

Published: March 22, 2023

Design and characterization of a heterobifunctional degrader of KEAP1.

Design and characterization of a heterobifunctional degrader of KEAP1.

Journal: Redox biology

Published: September 28, 2022

Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer.

Early immune pressure initiated by tissue-resident memory T cells sculpts tumor evolution in non-small cell lung cancer.

Journal: Cancer cell

Published: July 18, 2022

Showing 1-12 of 44

Last Updated: 09/26/2026